Page 13 - 《中国药房》2024年15期

我国静脉用药调配中心收费现状与收费标准调研分析
Δ

2
2 #
1＊
1
1
曹 捷 ，蔡雪峰 ，吕永宁 ，陈 骏 ，府裕琦 ，孙路路 （1.华中科技大学同济医学院附属协和医院药学部，
1
武汉 430022；2.国家卫生健康委医院管理研究所药事管理研究部，北京 100044）
中图分类号 R95 文献标志码 A 文章编号 1001-0408（2024）15-1807-05
DOI 10.6039/j.issn.1001-0408.2024.15.02
摘 要 目的 调研我国医疗机构静脉用药调配中心（PIVAS）的运营成本和现行收费政策等，为推动静脉用药集中调配工作高质
量、可持续发展提供参考。方法 2022 年 5 月 6 日至 7 月 1 日，通过“问卷星”平台向全国 30 个省、自治区和直辖市的医疗机构
PIVAS发放电子问卷，调研并分析PIVAS收费现状、运营成本及收费建议。结果 全国共有761个PIVAS参与调研，其中属于三级
医疗机构的666个，属于二级医疗机构的93个，属于一级医疗机构的2个。60.58%的PIVAS实行了收费制度，其中大多数PIVAS
需经过检查评估后方可收费。全国PIVAS总运营成本年均为209.81万元，其中综合运营成本占比高达89.36%，而调配成本仅占
10.64%。在各项费用中，人力成本是年均消耗最高的（占比74.20%），然后是房屋装修及维护成本（占比4.77%）、设备仪器购置成
本（占比3.44%）。对于各类药物的集中调配费用，普通药物在全国范围内的平均收费标准为4.39元/袋，抗菌药物平均为5.01元/袋，
危害药物平均为 23.17 元/袋，肠外营养液平均为 38.75 元/袋，而上述 4 种药物的建议平均收费标准分别为 6.71、9.63、38.35、44.03
元/袋。结论 我国目前尚无统一的检查评估标准和收费标准，且现行收费标准低于建议收费标准，需结合运营成本，制定更加合
理和公正的收费标准。
关键词 静脉用药调配中心；收费现状；收费标准；运营成本；调配成本；药师服务

Investigation and analysis of the charging status and standard of pharmacy intravenous admixture service
in China
2
1
2
CAO Jie ，CAI Xuefeng ，LYU Yongning ，CHEN Jun ，FU Yuqi ，SUN Lulu（1. Dept. of Pharmacy， Union
1
1
1
Hospital， Tongji Medical College， Huazhong University of Science and Technology， Wuhan 430022， China；
2. Dept. of Pharmaceutical Administration Research， National Institute of Hospital Administration， National
Health Commission， Beijing 100044， China）
ABSTRACT OBJECTIVE To investigate and analyze the operational costs and current charging policies of pharmacy intravenous
admixture service （PIVAS） in China， and provide a reference for promoting high-quality and sustainable development of PIVAS.
METHODS Questionnaires were distributed in 30 provinces， autonomous regions， and municipalities across the country through
the “Wenjuanxing” platform from May 6th to July 1st， 2022. The operational costs， charging status and suggestions of PIVAS were
investigated and analyzed. RESULTS A total of 761 PIVAS participated in the survey nationwide， including 666 tertiary medical
institutions， 93 secondary medical institutions， and 2 primary medical institutions. Approximately 60.58% of PIVAS had
implemented a charging system that allowed charges. Among them， most PIVAS required inspection and evaluation before charging.
The annual operating cost of PIVAS in China was approximately 2 098 100 yuan， with the integrated operating cost comprising
89.36% of the total， while the dispensing cost accounted for only 10.64%. Human costs emerged as the highest annual consumption
（74.20%）， followed by decoration and facility maintenance costs （4.77%） and equipment acquisition costs （3.44%）. Regarding
charges for different drugs nationwide， common drugs had an average charge standard of 4.39 yuan per bag while antibacterial
drugs averaged 5.01 yuan per bag； hazardous drugs had an average charge of 23.17 yuan per bag， whereas parenteral nutrition
solutions averaged 38.75 yuan per bag. However， the recommended average charges of the four drugs mentioned above were 6.71，
9.63， 38.35 and 44.03 yuan per bag， respectively. CONCLUSIONS At present， there is no unified inspection and evaluation
standard and charging standard in China. Moreover， the current charging standard is lower than the recommended standard. It is
necessary to combine operational costs and develop more
Δ 基金项目 国 家 卫 生 健 康 委 医 院 管 理 研 究 项 目（No. reasonable and fair charging standards.
202207200959000030162） KEYWORDS pharmacy intravenous admixture service；
＊第一作者 主管药师，硕士。研究方向：药事管理。电话：027-
charging status； charging standard； operational cost；
84395771。E-mail：whxh_caojie@163.com
dispensing cost； pharmacist service
# 通信作者 主任药师，硕士。研究方向：药事管理。电话：010-
81138590。E-mail：sunlulu@263.net

中国药房 2024年第35卷第15期 China Pharmacy 2024 Vol. 35 No. 15 · 1807 ·